Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus

• Main Authors: Elisabetta Bigagli (Author), Cristina Luceri (Author), Ilaria Dicembrini (Author), Lorenzo Tatti (Author), Francesca Scavone (Author), Lisa Giovannelli (Author), Edoardo Mannucci (Author), Maura Lodovici (Author)
• Format: Book
• Published: MDPI AG, 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pre-clinical studies suggested potential cardiovascular benefits of dipeptidyl peptidase-4 inhibitors (DPP4i), however, clinical trials showed neither beneficial nor detrimental effects in patients with type 2 diabetes mellitus (T2DM). We examined the effects of DPP4i on several circulating oxidativ...